Skip to content

4Accepted Jun 9, 8:53 AM ET

Garabedian Christopher Nishan 4

LABPLandos Biopharma, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

8:53 AM

Jun 9, 2022

Filed

Jun 9, 2022

Documents

1

Size

5.3 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.